Arca
Skip to content

Immunovant, Inc.

One private offering reported to the SEC on Form D since 2016, $450.0M sold in all. Pharma, NY.

  • Form D offerings: 1
  • Reported sold: $450.0M
  • Newest: Jan 21, 2025

Every Form D Offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
FiledSoldOfferingFiled asLast amendedFiling
Jan 21, 2025$450.0M$450.0MImmunovant, Inc.Pharma ยท NYNot amended0001231919-25-000012

SEC Profile

From the company's EDGAR record
Ticker
IMVT
Business address
Durham, Nc
Incorporated in
DE
SEC industry
Biological Products, (No Diagnostic Substances)
Former names
Health Sciences Acquisitions Corp
All SEC filings
CIK 1764013 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.